bo-1341 , a new antipseudomonal semisynthetic cephalosporin , was evaluated for in vitro and in vivo antibacterial activities in comparison with ceftazidime , cefotaxime , and cefoperazone .
C0279516
antibacterial
C0007554
cefotaxime